Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.
about
Serum amyloid A: an acute-phase protein involved in tumour pathogenesisExploring targeted therapy of osteosarcoma using proteomics dataStudying multiple protein profiles over time to assess biomarker validity.Comparison of algorithms for pre-processing of SELDI-TOF mass spectrometry data.Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma in China: a SELDI-TOF-MS study.Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11Plasma biomarkers in a mouse model of preterm labor.Identification of osteosarcoma-related specific proteins in serum samples using surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry.Biomarkers in Osteosarcoma.An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoringSerum tumor markers in pediatric osteosarcoma: a summary review.Discovery of biomarkers for osteosarcoma by proteomics approachesBiomarkers for Bone Tumours: Discovery from Genomics and Proteomics Studies and Their Challenges.Proteomic analysis of bone cancer: a review of current and future developments.Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines.An integrative multi-platform analysis for discovering biomarkers of osteosarcoma.Proteomic analysis of soft tissue sarcoma.Post-genomics of bone metabolic dysfunctions and neoplasias.Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media From Human Osteosarcoma Cell Lines Reveals Secretion of Proteins Related to Tumor Progression.Contrasting increased levels of serum amyloid A in patients with three different bone sarcomas: An indicator of tumor malignancy?The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.Single-nucleotide polymorphisms of the PRKCG gene and osteosarcoma susceptibility.
P2860
Q28291806-50AB5FED-8AE6-4F59-8902-E2E1A20BC130Q28817274-7DB843E1-C80B-4FA2-8E7A-1B71F5B81EADQ33253535-3ECFFBBD-DAAD-4804-A8D3-1F11420BBF4BQ33359328-2ACFD190-ACDA-44A6-A385-A7B18C9804ECQ33369053-2D17F7A3-8BAF-4F96-8D41-910006F9ED9BQ33388693-AD098068-7C83-4988-BB43-69634E33BFAEQ33418258-2CE0B5DF-35E6-4C1F-9AD8-016393E1FAD4Q33608263-9557B662-171A-4B66-9D6B-AEA0D9CDEC2DQ33929072-0CF3DA81-590E-4066-ABB2-0047C74BDF16Q33990542-2A7F3677-BFD1-41C8-859B-FA844D3C56E9Q35984687-3501E3F7-4A53-4065-8417-3E33A3F262BBQ36440338-59065B09-9072-43F5-85AC-543871A36F7FQ36758011-DE59CAAB-B104-4F03-90DC-D5E8F8848648Q36841875-B0531346-946B-4196-B24B-1B49C6F48DD5Q36884024-5E7DF803-B6A3-4EDB-A794-F7A0F1750CF8Q37214448-A9120E55-4F8F-421F-BA10-362F936A89C6Q37850740-560FCBA5-12A7-4112-907A-C61D9B65999BQ37975963-C0B46031-DEF8-4074-95C4-7AD93DA3B49AQ38445377-27920389-4740-404B-A863-487625AA88D0Q43672699-CAF61F84-F468-4660-8371-EDC9DA88A524Q45768840-ADE10726-CE4E-4F5F-BABC-6C9458C4DD40Q46036353-0147EBB8-22BE-4F3B-8003-B0D2CF980016Q54319898-AFB65419-CB00-4CC7-B59E-83656837BDD4
P2860
Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification of a plasma pro ...... ma from benign osteochondroma.
@ast
Identification of a plasma pro ...... ma from benign osteochondroma.
@en
type
label
Identification of a plasma pro ...... ma from benign osteochondroma.
@ast
Identification of a plasma pro ...... ma from benign osteochondroma.
@en
prefLabel
Identification of a plasma pro ...... ma from benign osteochondroma.
@ast
Identification of a plasma pro ...... ma from benign osteochondroma.
@en
P2093
P356
P1433
P1476
Identification of a plasma pro ...... ma from benign osteochondroma.
@en
P2093
Ching C Lau
Jeffrey Murray
Jianhe Shen
John Hicks
Laszlo Perlaky
Murali Chintagumpala
Tsz-Kwong Man
Tu Anh Dang
William Meyer
P2860
P304
P356
10.1002/PMIC.200500472
P577
2006-06-01T00:00:00Z